文章对血脂与卒中的关系以及调脂治疗在卒中预防和治疗中的作用进行综述。
This article reviews the relationship between lipids and stroke, as well as the role of lipid-modulating therapy in the prevention and treatment of stroke.
血脂康在调脂治疗的同时，可显著降低ET，提高NO、FMD，改善血管内皮功能。
While regulating blood lipid, Xuezhikang could markedly decrease ET and increase NO, FMD, as well as improve the endothelial function.
对血脂化验的参考值、高脂血症的分类、调脂治疗原则、调脂药物及其合理应用和尚待解决的问题作了回顾与展望。
This article reviewed the classification of hyperlipidemias, the blood lipid desirable level and current treatment guide-lines, and discussed lipid regulators and unresolved issues.
血脂康在调脂治疗的同时，可降低FINS及提高ISI，改善胰岛素抵抗。
While regulating blood lipid, Xuezhikang could markedly decrease FINS and increase ISI, as well as relief the insulin resistance.
本文对不同阶段的慢性肾脏疾病病人在各种血脂异常时的调脂治疗策略作一综述。
The strategies are reviewed for various types of dyslipidemia in various stages of chronic kidney disease in this paper.
目的观察非药物治疗对血脂异常患者的调脂效果。
Objective To observe the regulatory effect of non-pharmaceutical treatment on lipid profile in patients with dyslipidemia.
目的观察非药物治疗对血脂异常患者的调脂效果。
Objective To observe the regulatory effect of non-pharmaceutical treatment on lipid profile in patients with dyslipidemia.
应用推荐